Table 2.
Clinical and demographic details of patients and controls who contributed samples for IGF-1R staining.
| Case | Gender | Age | Smoker? | Duration of TED (months) | CAS |
|---|---|---|---|---|---|
| Non-Inflammatory TED 1 | M | 43 | Yes (20 years) | 9 | 1 |
| Non-Inflammatory TED 2 | M | 70 | No | 18 | 1 |
| Non-Inflammatory TED 3 | F | 47 | No | 12 | 1 |
| Non-Inflammatory TED 4 | F | 33 | No | 9 | 1 |
| Non-Inflammatory TED 5 | F | 57 | No | 108 | 1 |
| Inflammatory TED 1 | M | 29 | Yes (8 years) | 6 | 5 |
| Inflammatory TED 2 | M | 35 | Yes (10 years) | 14 | 4 |
| Inflammatory TED 3 | F | 50 | No | 88 | 3 |
| Inflammatory TED 4 | F | 49 | No | 15 | 3 |
| Inflammatory TED 5 | M | 53 | Yes (30 years) | 12 | 3 |
| Control 1 | M | 48 | No | – | – |
| Control 2 | F | 63 | No | – | – |
| Control 3 | M | 47 | No | – | – |
| Control 4 | F | 42 | No | – | – |
| Control 5 | M | 53 | No | – | – |